Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer

Thrombosis Research

Volumn 134, Issue 4, 2014, Pages 826-831

  Yamashita, Yo Ichi ^a   Bekki, Yuki ^a   Imai, Daisuke ^a   Ikegami, Toru ^a   Yoshizumi, Tomoharu ^a   Ikeda, Tetsuo ^a   Kawanaka, Hirofumi ^a   Nishie, Akihiro ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Enoxaparin; Hepatic resection; Liver cancer; Portal vein thrombosis

Indexed keywords

ENOXAPARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY MASS; DRUG EFFICACY; FEMALE; HUMAN; LIVER CANCER; LIVER RESECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; RISK FACTOR; SYMPTOMATOLOGY; VENOUS THROMBOEMBOLISM; COMPLICATION; DRUG EFFECTS; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; VENOUS THROMBOSIS;

AGED; ANTICOAGULANTS; ENOXAPARIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84908120969     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.07.038     Document Type: Article

References (45)

1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338S-400S.
2. Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol 2007;14:929-36.
3. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg 2006;141:790-7 [discussion 797-9].
4. Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007;24:250-8.
5. Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001;88:913-30.
6. Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci 2008;13:442-51.
7. Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thromb Res 2010;125:e65-70.
8. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997;337:688-98.
9. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-5.
10. Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M. PEGASUS investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 2005;92:1212-20.
11. Thomas RM, Ahmad SA. Management of acute post-operative portal venous thrombosis. J Gastrointest Surg 2010;14:570-7.
12. Miura K, Sato Y, Nakatsuka H, Yamamoto S, Oya H, Hara Y, et al. Catheter-directed continuous thrombolysis following aspiration thrombectomy via the ileocolic route for acute portal venous thrombosis: report of two cases. Surg Today 2013;43:1310-5.
13. Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 2005;241:208-16.
14. Yoshiya S, Shirabe K, Nakagawara H, Soejima Y, Yoshizumi T, Ikegami T, et al. Portal Vein Thrombosis After Hepatectomy. World J Surg 2014;38:1491-7.
15. Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, et al. Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 Years of Experience. J Am Coll Surg 2007;205:19-26.
16. Yamashita Y, Taketomi A, Morita K, Fukuhara T, Ueda S, Sanefuji K, et al. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res 2008;28:2353-9.
17. Yamashita Y, Adachi E, Toh Y, Ohgaki K, Ikeda O, Oki E, et al. Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases. Surg Today 2011;41:526-32.
18. Shimada M, Matsumata T, Shirabe K, Kamakura T, Taketomi A, Sugimachi K. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection. J Am Coll Surg 1994;178:498-502.
19. Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, et al. Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg 2001;136:328-33.
20. Chau GY, Lui WY, King KL, Wu CW. Evaluation of effect of hemihepatic vascular occlusion and the Pringlemaneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function. World J Surg 2005;29:1374-83.
21. Hirokawa F, Hayashi M, Miyamoto Y, Iwamoto M, Tsunematsu I, Asakuma M, et al. A novel method using the VIO soft-coagulation system for liver resection. Surgery 2011;149:438-44.
22. Tsujita E, Taketomi A, Kitagawa D, Itoh S, Harimoto N, Gion T, et al. Selective hepatic vascular exclusion for the hepatic resection of HCC. Hepatogastroenterology 2007;54:527-30.
23. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001;193:109-11.
24. Yamashita Y, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, et al. Bile leakage after hepatic resection. Ann Surg 2001;233:45-50.
25. Ikeda T, Mano Y, Morita K, Hashimoto N, Kayashima H, Masuda A, et al. Pure laparoscopic hepatectomy in semiprone position for right hepatic major resection. J Hepatobiliary Pancreat Sci 2013;20:145-50.
26. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96.
27. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011;149:713-24.
28. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 2011;149:680-8.
29. Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg Br 1981;63:171-7.
30. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg 2007;204:580-7.
31. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 2012;14:506-13.
32. Rosencher N, Bonnet MP, Sessler DI. Selected new antithrombotic agents and neuraxial anaesthesia for major orthopaedic surgery: management strategies. Anaesthesia 2007;62:1154-60.
33. Barrowcliffe TE, Johson EA, Thmas DP. Low Molecular Weight Heparin. New York: Wiley; 1992.
34. Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007;2:250-8.
35. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther 2007;26:141-8.
36. Louis SG, Barton JS, Riha GM, Orloff SL, Sheppard BC, Pommier RF, et al. The international normalized ratio overestimates coagulopathy in patients after major hepatectomy. Am J Surg 2014;207:723-7 [discussion 727].
37. Nathan H, Weiss MJ, Soff GA, Stempel M, Dematteo RP, Allen PJ, et al. Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. J Gastrointest Surg 2014;18:295-302 [discussion 302-3].
38. De Pietri L, Montalti R, Begliomini B, Scaglioni G, Marconi G, Reggiani A, et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability? Eur J Anaesthesiol 2010;27:608-16.
39. Weeder PD, Porte RJ, Lisman T. Hemostasis in Liver Disease: Implications of New Concepts for Perioperative Management. Transfus Med Rev Mar. 15 2014;28:107-13.
40. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-56.
41. Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, et al. Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy. J Gastrointest Surg 2014;18:1116-24.
42. Vivarelli M, Zanello M, Zanfi C, Cucchetti A, Ravaioli M, Del Gaudio M, et al. Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? World J Gastroenterol 2010;16:2146-50.
43. Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010;44:448-51.
44. Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012;143:1253-60.
45. Congly SE, Lee SS. Portal vein thrombosis: should anticoagulation be used? Curr Gastroenterol Rep 2013;15:306.